President Obama will have up until his last day in office to sign the 21st Century Cures Act into law.

Six years after the biggest overhaul of U.S. healthcare in half a century, the industry is bracing for more change under President-elect Donald Trump.

The ongoing intense policy debate over prescription drug costs may be a key factor in delaying progress on federal legislation on medical research.

Here are the four options qualifying providers may select from in order to begin participating for the first performance period, scheduled to begin January 1, 2017. Selecting an option is important to ensure that a practitioner is not penalized in 2019.

While the first year for the Medicare Access and CHIP Reauthorization Act is 2019, the performance period is 2017 (unless modified in the final rule). Thus, performance in 2017 will determine payment adjustments in 2019.